The peptide synthesis market size has grown strongly in recent years. It will grow from $6.18 billion in 2025 to $6.74 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to rising demand for peptide-based therapeutics, advances in solid-phase peptide synthesis, growth in academic and research institute studies, availability of high-purity reagents, demand from pharmaceutical r&d.
The peptide synthesis market size is expected to see rapid growth in the next few years. It will grow to $9.91 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to growth of contract manufacturing and research services, adoption of hybrid and recombinant peptide technologies, increasing collaborations between biotech and pharma companies, demand for custom peptide synthesis, advancements in peptide characterization and analytical technologies. Major trends in the forecast period include increasing use of ai for peptide design and optimization, expansion of precision medicine applications using peptides, integration of cloud and big data for peptide research, use of iot-enabled laboratory devices for real-time monitoring, implementation of smart manufacturing in peptide production.
The rising incidence of chronic diseases is expected to drive the growth of the peptide synthesis market in the coming years. Chronic diseases, also referred to as non-communicable diseases, are long-term health conditions that persist over extended periods and typically progress slowly. Peptide synthesis plays an important role in addressing chronic diseases, as certain peptides exhibit anti-inflammatory and antioxidant properties that can support the prevention and management of conditions such as cardiovascular diseases. Peptides can target specific cellular mechanisms and signaling pathways that underlie chronic illnesses, enabling the development of novel therapeutic and disease management approaches. For instance, in June 2025, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, noncommunicable diseases remain the leading cause of death and disability worldwide, including in the WHO European Region, with 1 in 5 men and 1 in 10 women dying before the age of 70 due to conditions such as cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes. Therefore, the growing burden of chronic diseases is driving the growth of the peptide synthesis market.
Major companies operating in the peptide synthesis market are concentrating on the development of next-generation peptide synthesizers to strengthen their competitive position. Advanced systems such as PurePep Sonata+ are designed to deliver greater efficiency, speed, and accuracy compared to conventional peptide synthesizers. For example, in August 2025, Vapourtec Ltd, a UK-based company specializing in flow-chemistry instrumentation, launched the Peptide-Builder, a compact benchtop peptide synthesizer. This system expands the capabilities of traditional synthesizers by incorporating Vapourtec’s Variable Bed Flow Reactor technology, enabling continuous-flow solid-phase peptide synthesis. The approach allows precise control of reaction conditions and supports high-throughput synthesis of multiple peptide sequences. In addition, the system features integrated automated software for sequence design, optimized coupling and deprotection processes, and real-time monitoring of resin volume and reaction progress, ensuring consistent and reproducible peptide production across a wide range of sequences and scales.
In May 2023, Biosynth International Inc., a Switzerland-based chemical manufacturing company, acquired Cambridge Research Biochemicals for an undisclosed amount. Through this acquisition, Biosynth strengthened its peptide division by gaining access to Cambridge Research Biochemicals’ extensive expertise in complex peptide chemistry and fluorescent dye labeling. Cambridge Research Biochemicals is a UK-based company specializing in the production of peptides, peptide synthesizers, antibodies, and related products.
Major companies operating in the peptide synthesis market are Thermo Fisher Scientific, Merck KGaA, Lonza Group, Kaneka Corporation, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd, MP Biomedicals, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix.
North America was the largest region in the peptide synthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peptide synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have affected the peptide synthesis market by increasing costs of imported reagents, peptide synthesizers, chromatography systems, and analytical instruments, particularly in North America and Europe. These tariffs have temporarily slowed adoption in pharmaceutical, biotech, and research sectors, but have also encouraged domestic manufacturing, fostered cost-effective innovation, and strengthened supply chain resilience for peptide production and services.
The peptide synthesis market research report is one of a series of new reports that provides peptide synthesis market statistics, including peptide synthesis industry global market size, regional shares, competitors with a peptide synthesis market share, detailed peptide synthesis market segments, market trends and opportunities, and any further data you may need to thrive in the peptide synthesis industry. This peptide synthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Peptide synthesis is the laboratory process of producing peptides, which are short chains of amino acids connected by chemical bonds. These synthesized peptides are widely used in research, drug development, and medical diagnostics, as they enable the creation of precise amino acid sequences that replicate specific epitopes within defined protein domains.
The primary products and services involved in peptide synthesis include reagents, equipment, and services. Reagents in peptide synthesis are the chemical compounds or substances used during the production process to form peptides through peptide bond formation. The technologies utilized include solid-phase peptide synthesis, solution-phase peptide synthesis, as well as hybrid and recombinant approaches. These products and technologies are used by various end users such as pharmaceutical and biotechnology companies, contract manufacturing and development organizations (CDMOs), contract research organizations (CROs), and academic and research institutes.
The peptide synthesis market consists of revenues earned by entities by providing synthesis optimization, chemical ligation technology, and group strategy protection. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptide synthesis market also includes sales of building blocks, chelators, coupling reagents, protecting reagents, amino acids, and resins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The peptide synthesis market size is expected to see rapid growth in the next few years. It will grow to $9.91 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to growth of contract manufacturing and research services, adoption of hybrid and recombinant peptide technologies, increasing collaborations between biotech and pharma companies, demand for custom peptide synthesis, advancements in peptide characterization and analytical technologies. Major trends in the forecast period include increasing use of ai for peptide design and optimization, expansion of precision medicine applications using peptides, integration of cloud and big data for peptide research, use of iot-enabled laboratory devices for real-time monitoring, implementation of smart manufacturing in peptide production.
The rising incidence of chronic diseases is expected to drive the growth of the peptide synthesis market in the coming years. Chronic diseases, also referred to as non-communicable diseases, are long-term health conditions that persist over extended periods and typically progress slowly. Peptide synthesis plays an important role in addressing chronic diseases, as certain peptides exhibit anti-inflammatory and antioxidant properties that can support the prevention and management of conditions such as cardiovascular diseases. Peptides can target specific cellular mechanisms and signaling pathways that underlie chronic illnesses, enabling the development of novel therapeutic and disease management approaches. For instance, in June 2025, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, noncommunicable diseases remain the leading cause of death and disability worldwide, including in the WHO European Region, with 1 in 5 men and 1 in 10 women dying before the age of 70 due to conditions such as cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes. Therefore, the growing burden of chronic diseases is driving the growth of the peptide synthesis market.
Major companies operating in the peptide synthesis market are concentrating on the development of next-generation peptide synthesizers to strengthen their competitive position. Advanced systems such as PurePep Sonata+ are designed to deliver greater efficiency, speed, and accuracy compared to conventional peptide synthesizers. For example, in August 2025, Vapourtec Ltd, a UK-based company specializing in flow-chemistry instrumentation, launched the Peptide-Builder, a compact benchtop peptide synthesizer. This system expands the capabilities of traditional synthesizers by incorporating Vapourtec’s Variable Bed Flow Reactor technology, enabling continuous-flow solid-phase peptide synthesis. The approach allows precise control of reaction conditions and supports high-throughput synthesis of multiple peptide sequences. In addition, the system features integrated automated software for sequence design, optimized coupling and deprotection processes, and real-time monitoring of resin volume and reaction progress, ensuring consistent and reproducible peptide production across a wide range of sequences and scales.
In May 2023, Biosynth International Inc., a Switzerland-based chemical manufacturing company, acquired Cambridge Research Biochemicals for an undisclosed amount. Through this acquisition, Biosynth strengthened its peptide division by gaining access to Cambridge Research Biochemicals’ extensive expertise in complex peptide chemistry and fluorescent dye labeling. Cambridge Research Biochemicals is a UK-based company specializing in the production of peptides, peptide synthesizers, antibodies, and related products.
Major companies operating in the peptide synthesis market are Thermo Fisher Scientific, Merck KGaA, Lonza Group, Kaneka Corporation, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd, MP Biomedicals, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix.
North America was the largest region in the peptide synthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peptide synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have affected the peptide synthesis market by increasing costs of imported reagents, peptide synthesizers, chromatography systems, and analytical instruments, particularly in North America and Europe. These tariffs have temporarily slowed adoption in pharmaceutical, biotech, and research sectors, but have also encouraged domestic manufacturing, fostered cost-effective innovation, and strengthened supply chain resilience for peptide production and services.
The peptide synthesis market research report is one of a series of new reports that provides peptide synthesis market statistics, including peptide synthesis industry global market size, regional shares, competitors with a peptide synthesis market share, detailed peptide synthesis market segments, market trends and opportunities, and any further data you may need to thrive in the peptide synthesis industry. This peptide synthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Peptide synthesis is the laboratory process of producing peptides, which are short chains of amino acids connected by chemical bonds. These synthesized peptides are widely used in research, drug development, and medical diagnostics, as they enable the creation of precise amino acid sequences that replicate specific epitopes within defined protein domains.
The primary products and services involved in peptide synthesis include reagents, equipment, and services. Reagents in peptide synthesis are the chemical compounds or substances used during the production process to form peptides through peptide bond formation. The technologies utilized include solid-phase peptide synthesis, solution-phase peptide synthesis, as well as hybrid and recombinant approaches. These products and technologies are used by various end users such as pharmaceutical and biotechnology companies, contract manufacturing and development organizations (CDMOs), contract research organizations (CROs), and academic and research institutes.
The peptide synthesis market consists of revenues earned by entities by providing synthesis optimization, chemical ligation technology, and group strategy protection. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptide synthesis market also includes sales of building blocks, chelators, coupling reagents, protecting reagents, amino acids, and resins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Peptide Synthesis Market Characteristics
3. Peptide Synthesis Market Supply Chain Analysis
4. Global Peptide Synthesis Market Trends and Strategies
5. Peptide Synthesis Market Analysis of End Use Industries
7. Global Peptide Synthesis Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Peptide Synthesis Total Addressable Market (TAM) Analysis for the Market
9. Peptide Synthesis Market Segmentation
10. Peptide Synthesis Market Regional and Country Analysis
11. Asia-Pacific Peptide Synthesis Market
12. China Peptide Synthesis Market
13. India Peptide Synthesis Market
14. Japan Peptide Synthesis Market
15. Australia Peptide Synthesis Market
16. Indonesia Peptide Synthesis Market
17. South Korea Peptide Synthesis Market
18. Taiwan Peptide Synthesis Market
19. South East Asia Peptide Synthesis Market
20. Western Europe Peptide Synthesis Market
21. UK Peptide Synthesis Market
22. Germany Peptide Synthesis Market
23. France Peptide Synthesis Market
24. Italy Peptide Synthesis Market
25. Spain Peptide Synthesis Market
26. Eastern Europe Peptide Synthesis Market
27. Russia Peptide Synthesis Market
28. North America Peptide Synthesis Market
29. USA Peptide Synthesis Market
30. Canada Peptide Synthesis Market
31. South America Peptide Synthesis Market
32. Brazil Peptide Synthesis Market
33. Middle East Peptide Synthesis Market
34. Africa Peptide Synthesis Market
36. Peptide Synthesis Market Competitive Landscape and Company Profiles
37. Peptide Synthesis Market Other Major and Innovative Companies
40. Peptide Synthesis Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Peptide Synthesis Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses peptide synthesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for peptide synthesis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peptide synthesis market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product And Service: Reagents; Equipment; Services2) By Technology: Solid-Phase Peptide Synthesis; Solution-Phase Peptide Synthesis; Hybrid And Recombinant Technology
3) By End User: Pharmaceutical And Biotechnology companies; Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs); Academic And Research Institutes
Subsegments:
1) By Reagents: Amino Acids; Coupling Reagents; Protecting Groups; Cleavage Reagents2) By Equipment: Peptide Synthesizers; Chromatography Systems; Mass Spectrometers
3) By Services: Custom Peptide Synthesis; Peptide Characterization And Analysis; Peptide Modification Services; Consulting And Support Services
Companies Mentioned: Thermo Fisher Scientific; Merck KGaA; Lonza Group; Kaneka Corporation; Guizhou Xinbang Pharmaceutical Co. Ltd.; Hybio Pharmaceutical Co. Ltd.; GenScript Biotech; Bachem Holding AG; Syngene International; PolyPeptide Group AG; CPC Scientific Inc.; New England Peptide Inc.; Biotage; ScinoPharm Taiwan Ltd; MP Biomedicals; CEM Corporation; Enamine Ltd.; Creative Diagnostics; AnaSpec Inc.; CSBio Company Inc.; Alfa Chemistry; Advanced ChemTech; Gyros Protein Technologies AB; AAPPTec LLC; Biosynth International Inc.; ProteoGenix
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Peptide Synthesis market report include:- Thermo Fisher Scientific
- Merck KGaA
- Lonza Group
- Kaneka Corporation
- Guizhou Xinbang Pharmaceutical Co. Ltd.
- Hybio Pharmaceutical Co. Ltd.
- GenScript Biotech
- Bachem Holding AG
- Syngene International
- PolyPeptide Group AG
- CPC Scientific Inc.
- New England Peptide Inc.
- Biotage
- ScinoPharm Taiwan Ltd
- MP Biomedicals
- CEM Corporation
- Enamine Ltd.
- Creative Diagnostics
- AnaSpec Inc.
- CSBio Company Inc.
- Alfa Chemistry
- Advanced ChemTech
- Gyros Protein Technologies AB
- AAPPTec LLC
- Biosynth International Inc.
- ProteoGenix
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.74 Billion |
| Forecasted Market Value ( USD | $ 9.91 Billion |
| Compound Annual Growth Rate | 10.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
